RHODOS Follow-up Single-visit Study

A Single Visit, Observational, Follow-up Study of Patients With Leber's Hereditary Optic Neuropathy Following Participation in SNT-II-003 Trial

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01421381

Acronym

RHODOS-OFU

Enrollment

Registered

2011-08-22

Start date

2011-09-30

Completion date

2011-12-31

Last updated

2013-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Leber's Hereditary Optic Neuropathy

Keywords

leber's hereditary optic neuropathy, idebenone

Brief summary

This study aims to evaluate the current visual acuity of SNT-II-003 participants and compare this with the last visit from the SNT-II-003 study.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

15 Years to 69 Years

Healthy volunteers

Inclusion criteria

* Previous participation in study SNT-II-003

Design outcomes

Primary

Measure	Time frame	Description
logMAR visual acuity	measure taken at the single study visit (Week 24)	Change in best logMAR visual acuity (Best Acuity) compared to Visit 2/Baseline and Visit 5/Week 24 or last treatment visit of SNT-II-003

Countries

Canada, Germany, United Kingdom

Outcome results